scholarly journals Lenvatinib in combination with everolimus in patients with advanced or metastatic renal cell carcinoma: A phase 1 study

2018 ◽  
Vol 25 (11) ◽  
pp. 922-928 ◽  
Author(s):  
Nobuaki Matsubara ◽  
Yoichi Naito ◽  
Kenji Nakano ◽  
Yutaka Fujiwara ◽  
Hiroki Ikezawa ◽  
...  
Keyword(s):  
Renal Cell Carcinoma ◽  
Cell Carcinoma ◽  
Metastatic Renal Cell Carcinoma ◽  
Renal Cell ◽  
Phase 1 ◽  
Phase 1 Study

scholarly journals Phase 1 study of everolimus and low-dose oral cyclophosphamide in patients with metastatic renal cell carcinoma

2018 ◽  
Vol 68 (2) ◽  
pp. 319-329 ◽  
Author(s):  
Charlotte M. Huijts ◽  
◽  
Inge M. Werter ◽  
Sinéad M. Lougheed ◽  
Ruben S. Goedegebuure ◽  
...  
Keyword(s):  
Renal Cell Carcinoma ◽  
Cell Carcinoma ◽  
Metastatic Renal Cell Carcinoma ◽  
Renal Cell ◽  
Low Dose ◽  
Phase 1 ◽  
Oral Cyclophosphamide ◽  
Phase 1 Study ◽  
Dose Oral

P0125 A phase 1/2 trial of BNC105P with everolimus in metastatic renal cell carcinoma

2015 ◽  
Vol 51 ◽  
pp. e26
Author(s):  
S. Pal ◽  
A. Azad ◽  
S. Bhatia ◽  
H. Drabkin ◽  
B. Costello ◽  
...  
Keyword(s):  
Renal Cell Carcinoma ◽  
Cell Carcinoma ◽  
Metastatic Renal Cell Carcinoma ◽  
Renal Cell ◽  
Phase 1

scholarly journals A Phase 1 Study of AS1409, a Novel Antibody-Cytokine Fusion Protein, in Patients with Malignant Melanoma or Renal Cell Carcinoma

2011 ◽  
Vol 17 (7) ◽  
pp. 1998-2005 ◽  
Author(s):  
Sarah M. Rudman ◽  
Michael B. Jameson ◽  
Mark J. McKeage ◽  
Philip Savage ◽  
Duncan I. Jodrell ◽  
...  
Keyword(s):  
Renal Cell Carcinoma ◽  
Malignant Melanoma ◽  
Fusion Protein ◽  
Cell Carcinoma ◽  
Renal Cell ◽  
Phase 1 ◽  
Phase 1 Study

scholarly journals A phase 1 trial of SGN‐CD70A in patients with CD70‐positive, metastatic renal cell carcinoma

Cancer ◽  
2019 ◽  
Vol 125 (7) ◽  
pp. 1124-1132 ◽  
Author(s):  
Sumanta K. Pal ◽  
Andres Forero‐Torres ◽  
John A. Thompson ◽  
John C. Morris ◽  
Saurabh Chhabra ◽  
...  
Keyword(s):  
Renal Cell Carcinoma ◽  
Cell Carcinoma ◽  
Metastatic Renal Cell Carcinoma ◽  
Renal Cell ◽  
Phase 1 ◽  
Phase 1 Trial

scholarly journals A phase 1 study of everolimus and sorafenib for metastatic clear cell renal cell carcinoma

Cancer ◽  
2011 ◽  
Vol 117 (18) ◽  
pp. 4194-4200 ◽  
Author(s):  
Andrea L. Harzstark ◽  
Eric J. Small ◽  
Vivian K. Weinberg ◽  
Janine Sun ◽  
Charles J. Ryan ◽  
...  
Keyword(s):  
Renal Cell Carcinoma ◽  
Cell Carcinoma ◽  
Renal Cell ◽  
Clear Cell ◽  
Phase 1 ◽  
Phase 1 Study ◽  
Cell Renal Cell Carcinoma
Sign in / Sign up

Export Citation Format

Share Document